PGNX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net margin is calculated as net income divided by its revenue. Progenics Pharmaceuticals Inc's net income for the three months ended in Dec. 2016 was $-7.20 Mil. Progenics Pharmaceuticals Inc's revenue for the three months ended in Dec. 2016 was $4.65 Mil. Therefore, Progenics Pharmaceuticals Inc's net margin for the quarter that ended in Dec. 2016 was -154.86%.
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Progenics Pharmaceuticals Inc's Net Margin for the fiscal year that ended in Dec. 2016 is calculated as
Progenics Pharmaceuticals Inc's Net Margin for the quarter that ended in Dec. 2016 is calculated as
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a companys profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Progenics Pharmaceuticals Inc Annual Data
Progenics Pharmaceuticals Inc Quarterly Data